Yu H - Search Results

1

Circulating Soluble Suppression of Tumorigenicity 2 Predicts Recurrence After Radiofrequency Ablation of Persistent Atrial Fibrillation.

Tan R, Yu H, Han X, Liu Y, Yang X, Xia YL, Yin X. Tan R, et al. Among authors: yu h. Front Cardiovasc Med. 2021 Jun 17;8:653312. doi: 10.3389/fcvm.2021.653312. eCollection 2021. Front Cardiovasc Med. 2021. PMID: 34222362 Free PMC article.

2

Acquired long QT syndrome in hospitalized patients.

Yu H, Zhang L, Liu J, Liu Y, Kowey PR, Zhang Y, Chen Y, Wei Y, Gao L, Li H, Du J, Xia Y. Yu H, et al. Heart Rhythm. 2017 Jul;14(7):974-978. doi: 10.1016/j.hrthm.2017.03.014. Epub 2017 Mar 18. Heart Rhythm. 2017. PMID: 28323171

3

Higher High-Sensitivity C Reactive Protein is Associated with Future Premature Ventricular Contraction: a Community Based Prospective Cohort Study.

Chen Y, Wu S, Li W, Wang B, Han X, Yang Y, Guan X, Yu H, Khalid BW, Li H, Xia Y. Chen Y, et al. Among authors: yu h. Sci Rep. 2018 Mar 26;8(1):5152. doi: 10.1038/s41598-018-22868-8. Sci Rep. 2018. PMID: 29581482 Free PMC article.

4

Hospitalized cancer patients with acquired long QT syndrome-a matched case-control study.

Lin Y, Yu H, Liu F, Chen C, Zhang Y, Wang B, Yang Y, Liu Y, Zhang L, Xia Y. Lin Y, et al. Among authors: yu h. Cardiooncology. 2020 Feb 14;6:3. doi: 10.1186/s40959-020-0057-2. eCollection 2020. Cardiooncology. 2020. PMID: 32154029 Free PMC article.

5

Identification of important risk factors for all-cause mortality of acquired long QT syndrome patients using random survival forests and non-negative matrix factorization.

Chen C, Zhou J, Yu H, Zhang Q, Gao L, Yin X, Dong Y, Lin Y, Li D, Yang Y, Wang Y, Tse G, Xia Y. Chen C, et al. Among authors: yu h. Heart Rhythm. 2021 Mar;18(3):426-433. doi: 10.1016/j.hrthm.2020.10.022. Epub 2020 Oct 28. Heart Rhythm. 2021. PMID: 33127541

6

Lipocalin-2 Predicts Long-Term Outcome of Normotensive Patients with Acute Pulmonary Embolism.

Yu H, Liu Z, Lu J, Yang X, Yan XX, Mi Y, Hua L, Li Y, Jing ZC, Du J. Yu H, et al. Cardiovasc Toxicol. 2020 Apr;20(2):101-110. doi: 10.1007/s12012-019-09525-w. Cardiovasc Toxicol. 2020. PMID: 31385242

7

Profilin 2 and Endothelial Exosomal Profilin 2 Promote Angiogenesis and Myocardial Infarction Repair in Mice.

Li Z, Huo X, Chen K, Yang F, Tan W, Zhang Q, Yu H, Li C, Zhou D, Chen H, Zhao B, Wang Y, Chen Z, Du X. Li Z, et al. Among authors: yu h. Front Cardiovasc Med. 2022 Apr 11;9:781753. doi: 10.3389/fcvm.2022.781753. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 35479278 Free PMC article.

8

Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL): A Novel Biomarker for Prognostic Assessment and Risk Stratification of Acute Pulmonary Embolism.

Yu H, Rong W, Yang J, Lu J, Ma K, Liu Z, Yuan H, Xu L, Li Y, Jing ZC, Du J. Yu H, et al. J Clin Med. 2022 Jul 5;11(13):3908. doi: 10.3390/jcm11133908. J Clin Med. 2022. PMID: 35807194 Free PMC article.

9

Missense mutation of SERPINC1 (p.Ser426Leu) in a young patient presenting as refractory and recurrent venous thromboembolism: A case report.

Yu H, Gai X, Wang J, Zhuang J, Guo W, Qiao R, Zhu H, Sun Y. Yu H, et al. Front Cardiovasc Med. 2022 Aug 24;9:903785. doi: 10.3389/fcvm.2022.903785. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 36093136 Free PMC article.

10

Association between triglyceride-glucose index trajectories and carotid atherosclerosis progression.

Yu H, Tao L, Li YG, Yang L, Liu D, Wang Y, Hao X, He H, Che Y, Wang P, Zhao W, Gao W. Yu H, et al. Cardiovasc Diabetol. 2023 May 31;22(1):130. doi: 10.1186/s12933-023-01847-y. Cardiovasc Diabetol. 2023. PMID: 37254140 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

39,289 results

Search Page

Filters